Topics

Companies Related to "Indivior Warns Potential Loss This Year Star Drug" [Most Relevant Company Matches] - Page: 3 [Advanced Search Results] RSS

15:38 EST 15th December 2019 | BioPortfolio

Here are the most relevant search results for "Indivior Warns Potential Loss This Year Star Drug" found in our extensive corporate database of over 50,000 company records.

Showing "Indivior Warns Potential Loss This Year Star Drug" Companies 51–75 of 6,500+

Relevant

Beryllium

Beryllium is shaping the future of collaborative drug discovery. Our proven teams of drug discovery professionals are passionate about unlocking the therapeutic potential of both genetically- and clinically-validated drug targets, and in developing new therapeutic modalities. We work in partnership with our clients to address the most difficult scientific ...


Prosetta Antiviral Inc.

Prosetta is a 9-year-old San Francisco-based biotechnology company with an innovative approach to drug discovery. The Prosetta platform emerged from 25 years of basic research on cell-free protein synthesizing systems (CFPSS) which validated CFPSS as an effective tool for approaching physiologically important protein-protein interactions, including host-vi...

Amneal Pharmaceuticals, Inc.

Reconciliation of Generics Operating (Loss) Income to Generics Combined Operating Loss


GTx, Inc. and Ipsen

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to prevent and treat cancer, fractures and bone loss, muscle loss and other serious medical conditions. For more information on GTx, visit our website, www.gtxinc.com....

Takeda San Diego

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. Multiple drug candidates discovered at TSD are currently in clinical trials including SYR322, a pot...

iWalk Inc.

iWalk Inc. is the pioneer and leader in personal bionic innovation. With the introduction of BiOM technology, the company has been able to embrace mobility and extend potential for people with lower-limb loss. In the future, the same underlying technology will also help people whose mobility is limited by stroke, diabetes or other conditions of disease or ...

L.J. Star Inc.

L.J. Star Incorporated provides an extensive line of process observation equipment – sight glasses, lights, sanitary fittings, and level gage instrumentation. Product lines include Metaglas® Safety Sight Windows, Lumiglas® Explosion Proof Lights and Cameras, Sight Flow Indicators, Sight Ports, Sanitary Clamps, Magnetic Level Gages and Gage Glass. ...

L.J. Star, Inc.

L.J. Star Incorporated provides an extensive line of process observation equipment – sight glasses, lights, sanitary fittings, and level gage instrumentation. Product lines include METAGLAS® Safety Sight Windows, Lumiglas® Explosion Proof Lights and Cameras, Visual Flow Indicators, Sight Ports, Sanitary Clamps, Magnetic Level Gages and Gage Glas...

Jumpstart Medicine

Since its founding in 2007, Jumpstart Medicine has helped thousands of individuals transform their lives through dramatic weight loss, improved health and sustained lifestyle improvements. Jumpstart's comprehensive, physician-supervised program delivers a balanced, low-calorie diet, one-on-one nutrition education, optional medication, exercise guidance and personalized lifestyle coaching. Its team...

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a product candidate for the potential treatment of gastroesophageal reflux disease, or GERD. Our drug discovery efforts focus on utilizing the body's natural nutrient transporter mechanisms to improve th...

Algos Therapeutics, Inc

Algos Therapeutics is a privately held, independent research company specializing in the evaluation of potential pain treatments under development. The data we generate from our models have proven highly predictive for activity in human pain. And, the information derived is invaluable for the discovery of potential breakthrough treatments for pain. This is a vital component of our clients’ pain ...

Arachnova

Arachnova has a focus on therapeutic switches, namely new uses for known drugs, and alternatively called 'drug reprofiling', 'drug repositioning' or 'drug repurposing'.Our approach is therapeutically eclectic, which we believe offers the greatest potential for project identificaion. We work with both partly and fully developed compounds, and we validate the new uses through an outsourced network o...

Trisomy 18 Foundation

Founded in 2002 by Victoria Miller after the loss of her baby son, Isaac, at 11 days old, the Trisomy 18 Foundation is now the nation's leading health advocacy organization serving families impacted by a Trisomy 18 diagnosis for a much-wanted child, a genetic condition causing high rates of infant mortality in the first year of life.

Mati Therapeutics, Inc.

Mati is developing the Evolute® sustained ocular drug delivery platform, which Mati believes has the potential to treat a range of ocular indications. The platform utilizes a device called a punctal plug, which is easily inserted into a patient’s punctum. The device has already been approved to treat dry eye syndrome, but Mati is the first to condu...

Outreach International

Outreach International (http://www.outreach-international.org/) has a 30-year record of success working with the poor to create sustainable solutions to their most urgent needs, including access to clean water, education, income, sustainable food sources, health care ... and self-reliance. The Missouri-based charity is one of only 0.2% of all U.S. charities to receive the Independent Charities of ...

Five Star Specialty Programs

Crump Insurance Services, Inc. (Crump P&C) is part of Crump Group, the nation’s largest insurance wholesaler. As the property & casualty insurance division of Crump Group, it is made up of Crump wholesale brokerage locations across the U.S. and in Bermuda, Five Star Specialty Programs and Hanleigh Insurance. Crump P&C is a market leading independent w...

Key Drug Prototyping

KeyDP develops new drugs based on the atomic details of the proteins that they target. KeyDP focuses on carefully identified targets with good drug potential. To this aim, KeyDP establishes strategic partnerships to complement its own focus on the molecular aspects of drug design and development. Our technology and business model will allow us to develop drugs faster and cheaper than current pract...

Hear the World Foundation

By supporting the charitable Hear the World Foundation, Sonova is campaigning for equal opportunities and a better quality of life for people with hearing loss. As a leading manufacturer of hearing care solutions, the company feels socially responsible for contributing towards a world where everyone has the chance to enjoy good hearing. For instance, the H...

Probably Relevant

The Star Group

Star Media

Nil

General Star

Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield’s product, PolyHeme®, is a human hemoglobin-based temporary oxygen-carrying red blood cell substitute. PolyHeme® simultaneously restores lost blood volum...

Micro Star Technologies

Micro Star Technologies (MST) was founded by Bernard Mesa in 1982, after 8 years of independent research, to produce ultramicrotomy diamond knives. Presently, MST supplies diamond knives to laboratories in 57 countries, where Micro Star is regarded as a standard of high quality and service.In the mid 90's MST developed a compact and affordable Cryo Ultramicrotome. Besides TEM sample sectioning, t...

Biotech Stock Letter

Biotech Stock Letter is an independent publisher focusing on the investment opportunities in the biotech sector and targeting undervalued biotechnology equities. Biotech Stock Letter is an email newsletter published twenty (20) times per year. Each issue of Biotech Stock Letter (BSL) focuses on a facet of the biotech industry such as pharmaceuticals treating a specific disease or a method of drug ...

Polyphenon Pharma

Polyphenon Pharma is a privately held subsidiary of the Japanese company, Mitsui Norin Co., Ltd., which discovered and manufactures the botanical drug Polyphenon E. Headquartered in New York, NY, Polyphenon Pharma focuses on the clinical development of Polyphenon E across a broad spectrum of therapeutic areas in which it has potential activity, including infectious disease/virology, urology, ...


More From BioPortfolio on "Indivior Warns Potential Loss This Year Star Drug"

Quick Search

Corporate Database Quicklinks